USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immatics Biotechnologies GmbH

USPTO PatentsView assignee record - 690 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Immatics ranks #648 of 49,997 tracked US assignees by granted-patent volume, with 690 patents across 15 technology areas.

#648
of 49,997 US assignees by volume
Top 12%
by Innovation Score (51.0/100)
18.8
avg claims per patent
+124%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R648 · Foreign Corporation #648 · 690 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 690 grants
  • TOP-DECILE #648/49,997
  • PHOTO-FINISH Rivian IP Holdings
  • CPC-FOCUS A61K · 15 areas
  • INNOV-PAR 51.0/100
  • CLAIMS-RICH 18.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +124% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rivian IP Holdings, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Immatics

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Immatics's Innovation Score is 51.0/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Immatics's grants concentrate

Immatics Biotechnologies GmbH is a focused PatentsView assignee: 15 CPC subclasses with 98.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (128 grants) versus a trough of 6 in 2016. By volume, Immatics sits between Cameron International Corporation and The Research Foundation for The State University of New York.

Immatics's three-year grant acceleration

From 2019–2021 to 2022–2024, Immatics Biotechnologies GmbH moved from 367 to 194 grants (0.53x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,625. See the growth leaderboard.

Who files at Immatics's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Immatics holds 690 patents at rank #648, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Immatics

By rank, the assignees closest to #648 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Immatics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Immatics, neither rank-band nor same-CPC leaders (those blocks stay above).

Immatics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

050100150 20152016201720182019202020212022202320242025 45
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Immatics Biotechnologies GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 8 1.2%
2016 6 0.9%
2017 7 1.0%
2018 63 9.1%
2019 115 16.7%
2020 128 18.6%
2021 124 18.0%
2022 64 9.3%
2023 51 7.4%
2024 79 11.4%
2025partial year 45 6.5%

Which technologies does Immatics Biotechnologies GmbH patent most?

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#648

of 49,997 tracked assignees

Innovation Score

51.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Immatics Biotechnologies GmbH's patent record in context - here's where to go next.

  • Immatics Biotechnologies GmbH's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 98.6% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #648 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Immatics Biotechnologies GmbH against Cameron International Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 51.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.